These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32914975)

  • 1. Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.
    Yokoyama T; Mizuguchi M
    J Med Chem; 2020 Dec; 63(23):14228-14242. PubMed ID: 32914975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery and development of transthyretin amyloidogenesis inhibitors: what are the lessons?
    Zhong B; Huang X; Zheng Y; Guo X; Wu L
    Future Med Chem; 2021 Dec; 13(23):2083-2105. PubMed ID: 34633220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
    Bulawa CE; Connelly S; Devit M; Wang L; Weigel C; Fleming JA; Packman J; Powers ET; Wiseman RL; Foss TR; Wilson IA; Kelly JW; Labaudinière R
    Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9629-34. PubMed ID: 22645360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
    Cotrina EY; Oliveira Â; Leite JP; Llop J; Gales L; Quintana J; Cardoso I; Arsequell G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis.
    Dohrn MF; Ihne S; Hegenbart U; Medina J; Züchner SL; Coelho T; Hahn K
    J Neurochem; 2021 Mar; 156(6):802-818. PubMed ID: 33155274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
    Choi S; Reixach N; Connelly S; Johnson SM; Wilson IA; Kelly JW
    J Am Chem Soc; 2010 Feb; 132(4):1359-70. PubMed ID: 20043671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
    J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors.
    Guo X; Liu Z; Zheng Y; Li Y; Li L; Liu H; Chen Z; Wu L
    Drug Des Devel Ther; 2020; 14():1057-1081. PubMed ID: 32210536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.
    Yokoyama T; Mizuguchi M
    J Med Chem; 2019 Feb; 62(4):2076-2082. PubMed ID: 30688456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
    Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
    Green NS; Foss TR; Kelly JW
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds.
    Yokoyama T; Mizuguchi M
    Biol Pharm Bull; 2018; 41(7):979-984. PubMed ID: 29962408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional Molecular Dynamics and Metadynamics Simulation Studies of the Binding and Unbinding Mechanism of TTR Stabilizers AG10 and Tafamidis.
    Zhou S; Ge S; Zhang W; Zhang Q; Yuan S; Lo GV; Dou Y
    ACS Chem Neurosci; 2020 Oct; 11(19):3025-3035. PubMed ID: 32915538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
    Connelly S; Mortenson DE; Choi S; Wilson IA; Powers ET; Kelly JW; Johnson SM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3441-3449. PubMed ID: 28625364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors.
    Yokoyama T; Kashihara M; Mizuguchi M
    J Med Chem; 2021 Oct; 64(19):14344-14357. PubMed ID: 34547896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis.
    Coelho T; Merlini G; Bulawa CE; Fleming JA; Judge DP; Kelly JW; Maurer MS; Planté-Bordeneuve V; Labaudinière R; Mundayat R; Riley S; Lombardo I; Huertas P
    Neurol Ther; 2016 Jun; 5(1):1-25. PubMed ID: 26894299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state.
    Petrassi HM; Johnson SM; Purkey HE; Chiang KP; Walkup T; Jiang X; Powers ET; Kelly JW
    J Am Chem Soc; 2005 May; 127(18):6662-71. PubMed ID: 15869287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.
    Johnson SM; Petrassi HM; Palaninathan SK; Mohamedmohaideen NN; Purkey HE; Nichols C; Chiang KP; Walkup T; Sacchettini JC; Sharpless KB; Kelly JW
    J Med Chem; 2005 Mar; 48(5):1576-87. PubMed ID: 15743199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTR fibril formation inhibitors: is there a SAR?
    Nencetti S; Orlandini E
    Curr Med Chem; 2012; 19(15):2356-79. PubMed ID: 22471984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.